- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Heart failure
- Meeting Date: July 2025
- Public Summary Document (PSD) July 2025 PBAC Meeting - (PDF)
- Public Summary Document (PSD) July 2025 PBAC Meeting - (Word)
Eplerenone – July 2025
Eplerenone; Tablet 25 mg, Tablet 50 mg; Inspra®
Last updated
9 July 2025